PL3946356T3 - Stosowanie baloksawiru do zapobiegania przenoszeniu wirusa grypy - Google Patents
Stosowanie baloksawiru do zapobiegania przenoszeniu wirusa grypyInfo
- Publication number
- PL3946356T3 PL3946356T3 PL20713011.3T PL20713011T PL3946356T3 PL 3946356 T3 PL3946356 T3 PL 3946356T3 PL 20713011 T PL20713011 T PL 20713011T PL 3946356 T3 PL3946356 T3 PL 3946356T3
- Authority
- PL
- Poland
- Prior art keywords
- baloxavir
- prevention
- transmission
- influenza virus
- influenza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19166228.7A EP3714889A1 (en) | 2019-03-29 | 2019-03-29 | Baloxavir for the prevention of transmission of influenza virus |
| PCT/EP2020/058573 WO2020201019A1 (en) | 2019-03-29 | 2020-03-26 | Compound and method for the prevention of transmission of influenza virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3946356T3 true PL3946356T3 (pl) | 2025-12-08 |
Family
ID=66041247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20713011.3T PL3946356T3 (pl) | 2019-03-29 | 2020-03-26 | Stosowanie baloksawiru do zapobiegania przenoszeniu wirusa grypy |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11389457B2 (pl) |
| EP (2) | EP3714889A1 (pl) |
| JP (1) | JP7579269B2 (pl) |
| KR (1) | KR20210146992A (pl) |
| CN (1) | CN113784719A (pl) |
| AU (2) | AU2020254906A1 (pl) |
| BR (1) | BR112021014421A2 (pl) |
| CA (1) | CA3129668A1 (pl) |
| ES (1) | ES3049656T3 (pl) |
| IL (1) | IL284990A (pl) |
| MX (1) | MX2021010834A (pl) |
| PL (1) | PL3946356T3 (pl) |
| WO (1) | WO2020201019A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112542250A (zh) * | 2020-11-04 | 2021-03-23 | 温州大学 | 基于优化seird模型的全球新冠病毒传播预测方法 |
| CN114601803B (zh) * | 2020-12-07 | 2023-08-01 | 谢斌 | 一种巴洛沙韦酯干混悬剂及其制备方法和应用 |
| KR20230062080A (ko) | 2021-10-29 | 2023-05-09 | 코웨이 주식회사 | 냉수 탱크 |
| CN118384167B (zh) * | 2024-04-19 | 2026-01-27 | 中国人民解放军军事科学院军事医学研究院 | 巴洛沙韦钠在治疗克里米亚-刚果出血热病毒感染方面的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7166435B2 (en) | 2001-08-06 | 2007-01-23 | The Quigley Corporation | Compositions and methods for reducing the transmissivity of illnesses |
| DK2444400T3 (en) | 2009-06-15 | 2018-06-18 | Shionogi & Co | SUBSTITUTED POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE |
| PL2620436T3 (pl) | 2010-09-24 | 2018-10-31 | Shionogi & Co., Ltd. | Prolek podstawionej policyklicznej pochodnej karbamoilopirydonowej |
| NZ736259A (en) | 2015-04-28 | 2019-09-27 | Shionogi & Co | Substituted polycyclic pyridone derivative and prodrugs thereof |
| KR102084109B1 (ko) | 2015-12-15 | 2020-03-03 | 시오노기세야쿠 가부시키가이샤 | 캡 의존적 엔도뉴클레아제 저해제 및 항인플루엔자 약을 조합하는 것을 특징으로 하는 인플루엔자 치료용 의약 |
| CR20190123A (es) | 2016-08-10 | 2019-04-30 | Shionogi & Co | Composiciones farmacéuticas que contienen derivados de piridona policíclicos sustituídos y profármacos de los mismos |
| TWI795462B (zh) * | 2017-11-17 | 2023-03-11 | 日商鹽野義製藥股份有限公司 | 光安定性及溶出性優異的醫藥製劑 |
| WO2020058745A1 (en) | 2018-09-18 | 2020-03-26 | Shionogi & Co., Ltd. | Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof |
| AU2019433734B2 (en) * | 2019-03-12 | 2025-08-28 | Shionogi & Co., Ltd. | Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a complication risk factor |
| US20220008429A2 (en) | 2019-03-22 | 2022-01-13 | Shionogi & Co., Ltd. | Treating influenza using substituted polycyclic pyridone derivatives and prodrugs thereof in a subject having influenza and a severe influenza condition |
| CA3146423A1 (en) | 2019-08-13 | 2021-02-18 | Stefan De Buck | Improved dosage of baloxavir marboxil for pediatric patients |
| US20210069204A1 (en) | 2019-08-13 | 2021-03-11 | F. Hoffmann-La Roche Ag | Dosage of baloxavir marboxil for pediatric patients |
-
2019
- 2019-03-29 EP EP19166228.7A patent/EP3714889A1/en active Pending
-
2020
- 2020-03-26 PL PL20713011.3T patent/PL3946356T3/pl unknown
- 2020-03-26 EP EP20713011.3A patent/EP3946356B1/en active Active
- 2020-03-26 CA CA3129668A patent/CA3129668A1/en active Pending
- 2020-03-26 CN CN202080025834.1A patent/CN113784719A/zh active Pending
- 2020-03-26 MX MX2021010834A patent/MX2021010834A/es unknown
- 2020-03-26 KR KR1020217035209A patent/KR20210146992A/ko active Pending
- 2020-03-26 AU AU2020254906A patent/AU2020254906A1/en not_active Abandoned
- 2020-03-26 ES ES20713011T patent/ES3049656T3/es active Active
- 2020-03-26 WO PCT/EP2020/058573 patent/WO2020201019A1/en not_active Ceased
- 2020-03-26 US US16/830,764 patent/US11389457B2/en active Active
- 2020-03-26 BR BR112021014421-8A patent/BR112021014421A2/pt unknown
- 2020-03-26 JP JP2021557775A patent/JP7579269B2/ja active Active
-
2021
- 2021-07-20 IL IL284990A patent/IL284990A/en unknown
- 2021-12-23 US US17/560,501 patent/US11911394B2/en active Active
-
2025
- 2025-10-15 AU AU2025252541A patent/AU2025252541A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3946356C0 (en) | 2025-08-27 |
| JP2022526366A (ja) | 2022-05-24 |
| EP3714889A1 (en) | 2020-09-30 |
| IL284990A (en) | 2021-09-30 |
| EP3946356A1 (en) | 2022-02-09 |
| WO2020201019A1 (en) | 2020-10-08 |
| US11911394B2 (en) | 2024-02-27 |
| MX2021010834A (es) | 2021-10-14 |
| KR20210146992A (ko) | 2021-12-06 |
| US20220331331A1 (en) | 2022-10-20 |
| BR112021014421A2 (pt) | 2021-10-05 |
| AU2020254906A1 (en) | 2021-08-19 |
| CA3129668A1 (en) | 2020-10-08 |
| AU2025252541A1 (en) | 2025-11-06 |
| US11389457B2 (en) | 2022-07-19 |
| ES3049656T3 (en) | 2025-12-17 |
| CN113784719A (zh) | 2021-12-10 |
| JP7579269B2 (ja) | 2024-11-07 |
| TW202102227A (zh) | 2021-01-16 |
| US20200330473A1 (en) | 2020-10-22 |
| EP3946356B1 (en) | 2025-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201700350D0 (en) | Altered virus | |
| EP4049159A4 (en) | PREVENTING RANSOMWARE | |
| PL3946356T3 (pl) | Stosowanie baloksawiru do zapobiegania przenoszeniu wirusa grypy | |
| IL286000A (en) | Asketamine for the treatment of depression | |
| GB201808617D0 (en) | Scaffold modification | |
| IL275573A (en) | Methods and preparations for the treatment of hypercytokinemia and severe influenza or for their prevention | |
| GB202102049D0 (en) | Viruses | |
| IL279726A (en) | The hemagglutinin mutants of the influenza virus | |
| GB2578864B (en) | Trusted ring | |
| GB201820983D0 (en) | Virus | |
| ZA202207121B (en) | Immobilization of phenolic compounds | |
| GB201916292D0 (en) | Viruses | |
| HK40080663A (zh) | 用於预防hiv的衣壳抑制剂 | |
| HK40070131A (en) | Influenza virus backbone | |
| HK40055549A (en) | Integrase inhibitors for the prevention of hiv | |
| HK40039903A (en) | Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza | |
| EP3841893A4 (en) | COMPOSITION FOR PREVENTING TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS | |
| GB201912372D0 (en) | Universal balustrading | |
| GB201918058D0 (en) | The generic approach of the blockchain interoperability | |
| EP4054551A4 (en) | INHIBITORS OF INFLUENZA VIRUS ENTRY | |
| EP3928018A4 (en) | FLANGE | |
| HK40021231A (en) | Combination therapies for treating influenza virus infection | |
| AU2019901137A0 (en) | Novel viruses | |
| HK40039977A (en) | Viral particle - based vaccine | |
| HK40047014A (en) | Influenza virus hemagglutinin mutants |